Stereotaxis Inc  

(Public, NASDAQ:STXS)   Watch this stock  
Find more results for Fred Mills
3.94
-0.18 (-4.37%)
Apr 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.92 - 4.11
52 week 1.21 - 10.85
Open 4.11
Vol / Avg. 0.00/409,233.00
Mkt cap 76.07M
P/E     -
Div/yield     -
EPS -4.73
Shares 19.31M
Beta 2.71
Inst. own 30%
May 12, 2014
Q1 2014 Stereotaxis Inc. Earnings Release (Estimated) Add to calendar
Feb 25, 2014
Q4 & FY 2013 Stereotaxis Inc Earnings Conference Call - Webcast
Feb 25, 2014
Q4 & FY 2013 Stereotaxis Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -43.69% -180.79%
Operating margin -26.73% -23.25%
EBITD margin - -23.25%
Return on average assets -55.33% -217.44%
Return on average equity - -
Employees 134 -
CDP Score - -

Address

Suite 100, 4320 Forest Park Avenue
ST. LOUIS, MO 63108
United States - Map
+1-314-6786100 (Phone)
+1-314-6786159 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Stereotaxis, Inc. is a United States-based company that develops probes, devices, therapeutic and magnetic surgery delivery systems. The Company provides therapeutic delivery systems for the brain and central nervous system using magnetic stereotaxis. Its technology uses for surgical procedures and for the delivery of drugs to specific regions in the brain. Stereotaxis System is a remote-controlled magnetic instrument control and navigation platform that allows physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites and then to effect treatment.

Officers and directors

William C. Mills III Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Martin C. Stammer Chief Financial Officer
Age: 32
Bio & Compensation  - Reuters
Karen W. Duros Senior Vice President, General Counsel, Secretary
Age: 58
Bio & Compensation  - Reuters
Frank J. Cheng Senior Vice President - Marketing and Business Development
Age: 45
Bio & Compensation  - Reuters
David A. Giffin Vice President - Human Resources
Age: 64
Bio & Compensation  - Reuters
David W. Benfer Independent Director
Age: 66
Bio & Compensation  - Reuters
Joseph D. Keegan Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Robert J. Messey Independent Director
Age: 67
Bio & Compensation  - Reuters
Fred A. Middleton Independent Director
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Eric N. Prystowsky M.D. Independent Director
Age: 65
Bio & Compensation  - Reuters